Wire Stories
Virpax Pharmaceuticals Engages New England Investors to Direct Licensing Strategy for Envelta� in China
BERWYN, Pa.–(BUSINESS WIRE)–#pharma—Virpax� Pharmaceuticals, Inc. (�Virpax� or the �Company�) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic...